Microbial Ecosystem Therapeutics 2 (MET-2) & Ulcerative colitis (UC)

Concerning Microbial Ecosystem Therapeutics 2 (MET-2) & Ulcerative colitis (UC), Microbial Ecosystem Therapeutics 2 (MET-2) is an investigational therapy designed to restore gut microbial balance, currently being evaluated for conditions like ulcerative colitis (UC). There are no published clinical trial results or regulatory approvals from the FDA or EMA specifically linking MET-2 to UC treatment. Literature generally discusses the potential of precision microbiota therapies for managing inflammatory bowel diseases, including UC, but does not specifically mention MET-2 in clinical or regulatory contexts (1, 2).

References:

(1) Basso et al. 2019 Front. Pharmacol. 9: 1571
(2) Nagayama et al. 2025 Gut Microbes 17(1): 2489067

see also:
Fecal Microbiota Transplantation (FMT) & Ulcerative Colitis (UC)
Probiotics (living agents) & Ulcerative Colitis (UC)